Vesprini, D., Narod, S. A., Trachtenberg, J., Crook, J., Jalali, F., Preiner, J., . . . Bristow, R. G. (2011). The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers. Canadian Medical Association.
Citação norma ChicagoVesprini, Danny, Steven A. Narod, John Trachtenberg, Juanita Crook, Farid Jalali, John Preiner, Srikala Sridhar, and Robert G. Bristow. The Therapeutic Ratio Is Preserved for Radiotherapy or Cisplatin Treatment in BRCA2-mutated Prostate Cancers. Canadian Medical Association, 2011.
MLA citiranjeVesprini, Danny, et al. The Therapeutic Ratio Is Preserved for Radiotherapy or Cisplatin Treatment in BRCA2-mutated Prostate Cancers. Canadian Medical Association, 2011.
Opozorilo: Ti citati niso vedno 100% točni.